Eran Ovadya
Director Financiero/CFO en NUREXONE BIOLOGIC INC. .
Fortuna: 198 475 $ al 30/04/2024
Cargos activos de Eran Ovadya
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NUREXONE BIOLOGIC INC. | Director Financiero/CFO | 15/06/2022 | - |
Historial de carrera de Eran Ovadya
Antiguos cargos conocidos de Eran Ovadya.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VVT Medical Ltd. | Director Financiero/CFO | - | - |
Silexion Therapeutics Ltd.
 Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Director Financiero/CFO | - | - |
Estadísticas
Internacional
| Israel | 3 |
| Canadá | 2 |
Operativa
| Director of Finance/CFO | 3 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NUREXONE BIOLOGIC INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Health Technology |
| VVT Medical Ltd. |
- Bolsa de valores
- Insiders
- Eran Ovadya
- Experiencia
